HOME >> MEDICINE >> NEWS
Leading immunosuppressant CellCept significantly extends the lifespan of transplanted kidneys

The analysis showed that after three years treatment with CellCept + tacrolimus, kidney survival was 85.9% versus 80.3% with patients taking sirolimus + tacrolimus immunosuppressants. The outcome was even better for higher risk patients with a kidney survival rate of 74.5% vs 57.5%[i]. The new data were presented at the European Society for Organ Transplantation (ESOT), Geneva, Switzerland. Previous data have shown that CellCept gives a survival benefit when compared to older immunosuppressant drugs and now these new data demonstrate the survival benefit of CellCept combinations over the newer drug regimens.

Kidneys are the most commonly transplanted organs[ii]; for every kidney available there are four people waiting to receive one[iii]. After transplantation, people need to take a combination of immunosuppressant drugs for the rest of their lives to prevent the body rejecting the new organ. By preserving the transplanted organ with CellCept based combinations, doctors can help patients to keep their organs longer, thereby, reducing the burden on the already limited donor pool. One way to achieve this is by choosing combinations based on the low toxicity profile of CellCept, along with reduced doses of the more toxic immunosuppressant drugs to decrease the risk of losing the new kidney.

"We have learnt that the combination of cyclosporine/sirolimus is toxic to the kidney over time and as a result some doctors have switched to a sirolimus/tacrolimus combination, that was perceived to be less toxic," said Prof Herwig-Ulf Meier Kriesche, University of Florida, Gainesville, Fl, USA. "Now we have the data to show that this combination is just as damaging. These data, along with this latest analysis of patients on CellCept combinations, should help us make an evidence-based choice on how best to reduce the risk of toxicity, which we know is associated with some long-term immunosuppressant regimens," he added.


'"/>

Contact: Helen Swift
helen.swift@ketchum.com
+44-20-7611-3637
Ketchum
19-Oct-2005


Page: 1

Related medicine news :

1. Leading prevention researchers meeting in Washington, D.C., May 30-June 1, 2007
2. Leading advocates express support for microbicide research, despite disappointing trial results
3. Leading European experts in magnetic resonance for animals
4. Leading healthcare authorities to address safety and effectiveness
5. Leading international osteoporosis experts to present at worlds largest osteoporosis congress
6. Leading hepatology textbook edited by SLU researchers
7. Leading groups offer NIH direct links to journals to make research access easy for public
8. Leading pediatricians group recommends infants sleep in cribs, not parents beds
9. Leading genomic technology expert to present Dickson Prize Lecture at Pitt
10. Leading experts discuss how to protect premature infants against RSV, a potentially dangerous virus
11. Leading sleep expert at Wake Forest to speak at NIH Consensus Conference

Post Your Comments:
(Date:5/28/2015)... Newton, Mass. (PRWEB) May 28, 2015 ... a $17.5 million round of financing led by ... health solutions company dedicated to transforming health care by ... nation’s largest and most utilized network for exchanging medical ... its growing customer base, increase the breadth of its ...
(Date:5/28/2015)... Cancer survivors who participated in the LIVESTRONG ... fitness and quality of life, according to research conducted ... Jennifer Ligibel, MD, senior physician in the Susan F. ... The findings will be presented at this year’s ... in Chicago. , The study, designed to ...
(Date:5/28/2015)... Ask not what your racquet can do for ... with your racquet. With the launch of their new digital ... his astonishing tricks and unique skill to HEAD Pro Players ... the trick artist playfully demonstrates how to gain more control ... way, but also challenges tennis enthusiasts everywhere to join the ...
(Date:5/28/2015)... 2015 The report “Dystonia – ... the therapeutic development for Dystonia. Dystonia is characterized ... often repetitive, movements, postures, or both. Dystonia affects ... backgrounds. The report strengthens R&D pipelines by identifying ... best-in-class products. Complete report on H1 2015 pipeline ...
(Date:5/28/2015)... Orem, UT—Dymicron, Inc., (dymicron.com) confirmed the successful completion ... cervical total disc replacement device. The two surgeries were ... the American Institute of Minimally Invasive Surgery (AIMIS) in ... the implantation of the Dymicron devices,” said Dr. William ... of Neurosurgery for the University Medical Center, Las Vegas, ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2
(Date:5/27/2015)... 27, 2015 PharmaPoint: Systemic Lupus Erythematosus and ... to 2022 - Event-Driven Update Summary ... GlaxoSmithKline,s Benlysta is the only drug that has gained ... Following Benlysta,s launch, patients, uptake has remained low, but ... to grow the lupus market in terms of value ...
(Date:5/27/2015)... 2015 ... the addition of the  "2015 Strategies in ...  report to their offering.      ... to the US NAT laboratory practice, as ... and technological trends with significant market impact ...
(Date:5/27/2015)... Research and Markets ( ... the  "Asia Pacific Ultrasound Devices Market - ...  company profile to their offering.  ... is a type of imaging. It uses ... parts and structures inside the body. Health ...
Breaking Medicine Technology:PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3United States Nucleic Acid Testing Market Strategies 2015-2020 2Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2
Cached News: